Because the reduced dietary Zn levels induced resistance to pharmacological treatment, we wanted to determine whether the antidepressant-like activities of atypical drugs somehow correlated with the Zn concentrations in the Hp and FC, which are two crucial brain structures involved in the regulation of depression-like behaviors. The gene discussed is HP; the disease is major depressive disorder.